Dr. Flavell is Sterling Professor of Immunobiology at Yale University School of Medicine, and an Investigator of the Howard Hughes Medical Institute. His research focuses on innate and adaptive immunity, T-cell tolerance and activation in immunity and autoimmunity, apoptosis, and regulation of T-cell differentiation.
He received his B.Sc. (Honors) and Ph.D. in biochemistry from the University of Hull, England, and performed postdoctoral work in Amsterdam with Piet Borst and in Zurich with Charles Weissmann. Dr. Flavell is a fellow of the Royal Society, a member of the National Academy of Sciences as well as the Institute of Medicine.